{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "25428260",
        "25283840"
      ],
      "tumorType":{
        "children":{},
        "code":"SMZL",
        "color":"LimeGreen",
        "id":578,
        "level":6,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Splenic Marginal Zone Lymphoma",
        "parent":"MZL",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"KLF2, a transcription factor that regulates the activity of NF-\u03baB, is recurrently altered by mutation in splenic marginal zone lymphoma.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx3",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"03/04/2019",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "25428260",
        "25283840"
      ]
    },
    "description":"Truncating mutations in KLF2 occur throughout the protein as frameshift indels and nonsense mutations (PMID: 25428260, 25283840). Truncating variants that delete 1-3  zinc finger domains have a reduced ability to suppress NF-\u03baB transcriptional activity, as evidenced in reporter assays in lymphoma and 293T cell lines (PMID: 25428260, 25283840). In addition, the expression of KLF2 truncating mutations failed to regulate the activity of NF-\u03baB in response to a variety of stimulants that initiate TNF-receptor, TLR (toll-like receptor), canonical and non-canonical NF-\u03baB pathways, suggesting a defect in binding of KLF2 to DNA (PMID: 25428260).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"A229Lfs*27",
    "alterationType":null,
    "consequence":"frameshift_variant",
    "entrezGeneId":10365,
    "hgvs":null,
    "hugoSymbol":"KLF2",
    "id":null,
    "proteinEnd":258,
    "proteinStart":224,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The KLF2 A229Lfs*27 mutation is likely oncogenic.",
  "vus":false
}